BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 27527699)

  • 1. Resistance to Macrolide Antibiotics in Public Health Pathogens.
    Fyfe C; Grossman TH; Kerstein K; Sutcliffe J
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27527699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
    Walsh F; Willcock J; Amyes S
    J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of 23S rRNA nucleotide G748 by RlmAII methyltransferase renders Streptococcus pneumoniae telithromycin susceptible.
    Takaya A; Sato Y; Shoji T; Yamamoto T
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3789-96. PubMed ID: 23716046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominance of 23S rRNA mutants among non-erm, non-mef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999-2000.
    Davies TA; Bush K; Sahm D; Evangelista A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3031-3. PubMed ID: 15980393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.
    Tait-Kamradt A; Davies T; Cronan M; Jacobs MR; Appelbaum PC; Sutcliffe J
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2118-25. PubMed ID: 10898684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis.
    Pereyre S; Gonzalez P; De Barbeyrac B; Darnige A; Renaudin H; Charron A; Raherison S; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3142-50. PubMed ID: 12234836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.
    Van Eldere J; Meekers E; Lagrou K; Massonet C; Canu A; Devenyns I; Verhaegen J; Syrogiannopoulos G; Leclercq R
    Clin Microbiol Infect; 2005 Apr; 11(4):332-4. PubMed ID: 15760433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
    Reinert RR; Al-Lahham A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.
    Farrell DJ; Douthwaite S; Morrissey I; Bakker S; Poehlsgaard J; Jakobsen L; Felmingham D
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1777-83. PubMed ID: 12760848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide Resistance in
    Schroeder MR; Stephens DS
    Front Cell Infect Microbiol; 2016; 6():98. PubMed ID: 27709102
    [No Abstract]   [Full Text] [Related]  

  • 12. Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany.
    Reinert RR; Wild A; Appelbaum P; Lütticken R; Cil MY; Al-Lahham A
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2319-22. PubMed ID: 12821488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous macrolide resistance and gene conversion in the pneumococcus.
    Wolter N; Smith AM; Farrell DJ; Klugman KP
    Antimicrob Agents Chemother; 2006 Jan; 50(1):359-61. PubMed ID: 16377711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
    Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila.
    Descours G; Ginevra C; Jacotin N; Forey F; Chastang J; Kay E; Etienne J; Lina G; Doublet P; Jarraud S
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations.
    Malbruny B; Nagai K; Coquemont M; Bozdogan B; Andrasevic AT; Hupkova H; Leclercq R; Appelbaum PC
    J Antimicrob Chemother; 2002 Jun; 49(6):935-9. PubMed ID: 12039885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America.
    Tait-Kamradt A; Davies T; Appelbaum PC; Depardieu F; Courvalin P; Petitpas J; Wondrack L; Walker A; Jacobs MR; Sutcliffe J
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3395-401. PubMed ID: 11083646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance.
    Svetlov MS; Syroegin EA; Aleksandrova EV; Atkinson GC; Gregory ST; Mankin AS; Polikanov YS
    Nat Chem Biol; 2021 Apr; 17(4):412-420. PubMed ID: 33462493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of α-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA.
    Sugiyama H; Yoshida I; Ueki M; Tanabe K; Manaka A; Hiramatsu K
    J Antibiot (Tokyo); 2017 Mar; 70(3):264-271. PubMed ID: 28074049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
    Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
    Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.